COVID-19 in a patient with idiopathic pulmonary fibrosis successfully treated with Ruxolitinib

Detalles Bibliográficos
Autores principales: Caradec, E., Mouren, D., Zrounba, M., Azoulay, L.-D., Blandin, C., Ivanoff, S., Levy, V., Brillet, P.-Y., Nunes, H., Uzunhan, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647390/
https://www.ncbi.nlm.nih.gov/pubmed/33242734
http://dx.doi.org/10.1016/j.resmer.2020.100799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647390/
https://www.ncbi.nlm.nih.gov/pubmed/33242734
http://dx.doi.org/10.1016/j.resmer.2020.100799

Ejemplares similares